Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 2/24/2026 | $41.00 | Buy | Stifel |
| 10/21/2024 | $56.00 | Underweight → Neutral | JP Morgan |
| 12/4/2023 | Buy → Hold | Argus | |
| 7/11/2023 | $73.00 → $65.00 | Outperform → Neutral | Robert W. Baird |
| 10/27/2021 | $105.00 | Buy | Seaport Global |
| 9/22/2021 | $94.00 | Outperform | Robert W. Baird |
| 9/22/2021 | $94.00 | Outperform | Baird |
| 7/30/2021 | $85.00 → $92.00 | Buy | Roth Capital |
4 - Gentherm Inc (0000903129) (Issuer)
4 - Gentherm Inc (0000903129) (Issuer)
4 - Gentherm Inc (0000903129) (Issuer)
NOVI, Mich., July 22, 2026 (GLOBE NEWSWIRE) -- Gentherm (NASDAQ:THRM), a global market leader of innovative thermal management and pneumatic comfort technologies, today announced it has acquired Innovative Medical Equipment, LLC (IME), a Cleveland-area provider of the ThermaZone® thermal therapy device. The acquisition supports Gentherm's strategy to strengthen its Medical business through a strategic investment that expands its product portfolio. IME adds an established technology platform and customer base that expands Gentherm’s addressable opportunities in healthcare while remaining aligned with the Company’s broader expertise. ThermaZone is a non-opioid thermal therapy solution desig
NOVI, Mich., July 20, 2026 (GLOBE NEWSWIRE) -- Gentherm, a global market leader of innovative thermal management and pneumatic comfort technologies, announced today it received FDA 510(k) clearance for its patented ThermAffyx™ Patient Safety System. This Class II medical device combines active patient warming, securement and pressure reduction in a single platform designed for the more than 3 million robotic-assisted surgical procedures performed annually worldwide. Product trials at healthcare facilities are scheduled to begin in August, with revenue generation expected to commence in Q3 2026. Historically, surgical teams have pieced together separate solutions to address warming and sec
NOVI, Mich., July 07, 2026 (GLOBE NEWSWIRE) -- Gentherm (NASDAQ:THRM), a global market leader of innovative thermal management and pneumatic comfort technologies, will report its financial results for the second quarter 2026 on Thursday, July 23, 2026, and will host a conference call to discuss those results at 8 am (ET) that same day. Conference CallToll-free dial-in number: 1-877-407-4018International dial-in number: 1-201-689-8471Conference ID number: 13761564 WebcastA live webcast and one-year archived replay of the call can be accessed on the Events page of the Investor Relations section of Gentherm's website at www.gentherm.com. A telephonic replay will be available approximately
4 - Gentherm Inc (0000903129) (Issuer)
4 - Gentherm Inc (0000903129) (Issuer)
4 - Gentherm Inc (0000903129) (Issuer)
Stifel initiated coverage of Gentherm with a rating of Buy and set a new price target of $41.00
JP Morgan upgraded Gentherm from Underweight to Neutral and set a new price target of $56.00
Argus downgraded Gentherm from Buy to Hold
SCHEDULE 13G - Gentherm Inc (0000903129) (Subject)
425 - Gentherm Inc (0000903129) (Subject)
8-K - Gentherm Inc (0000903129) (Filer)
Findley has a demonstrated record of accelerating growth and transformation across diverse consumer business models Phillip Eyler to become independent Board Chair, effective after the 2025 Annual Meeting of Shareholders Sleep Number Corporation (NASDAQ:SNBR) today announced that its Board of Directors (the "Board") has appointed Linda Findley as the company's new President and Chief Executive Officer, and as a member of the Board, effective April 7, 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250305807579/en/Linda Findley will assume the role of Sleep Number President and CEO on April 7, 2025 (Photo: Business Wire) Fi
NORTHVILLE, Mich., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Gentherm (NASDAQ:THRM), the global market leader of innovative thermal management and pneumatic comfort technologies for the automotive industry and a leader in medical patient temperature management systems, today announced that Jonathan ("Jon") Douyard will join the Company's leadership team as Executive Vice President, Chief Financial Officer and Treasurer, effective January 1, 2025. Douyard will lead all of Gentherm's finance, treasury, investor relations, and IT operations on a global basis, reporting to Gentherm's next President and CEO, Bill Presley. Douyard succeeds Matteo Anversa, who served as CFO until September 2024 when he
NORTHVILLE, Mich., Oct. 02, 2023 (GLOBE NEWSWIRE) -- Gentherm (NASDAQ:THRM), the global market leader of innovative thermal management and pneumatic comfort technologies for the automotive industry and a leader in medical patient temperature management systems, today announced that Dr. Ken Washington has been appointed to the Company's Board of Directors, effective October 2, 2023. Dr. Washington is the Senior Vice President, Chief Technology and Innovation Officer of Medtronic plc (NYSE:MDT), a global healthcare technology company that provides device-based medical therapies and services. He was appointed to this position in June 2023, and he leads innovation and the expansion of technol
NOVI, Mich., July 22, 2026 (GLOBE NEWSWIRE) -- Gentherm (NASDAQ:THRM), a global market leader of innovative thermal management and pneumatic comfort technologies, today announced it has acquired Innovative Medical Equipment, LLC (IME), a Cleveland-area provider of the ThermaZone® thermal therapy device. The acquisition supports Gentherm's strategy to strengthen its Medical business through a strategic investment that expands its product portfolio. IME adds an established technology platform and customer base that expands Gentherm’s addressable opportunities in healthcare while remaining aligned with the Company’s broader expertise. ThermaZone is a non-opioid thermal therapy solution desig
NOVI, Mich., July 07, 2026 (GLOBE NEWSWIRE) -- Gentherm (NASDAQ:THRM), a global market leader of innovative thermal management and pneumatic comfort technologies, will report its financial results for the second quarter 2026 on Thursday, July 23, 2026, and will host a conference call to discuss those results at 8 am (ET) that same day. Conference CallToll-free dial-in number: 1-877-407-4018International dial-in number: 1-201-689-8471Conference ID number: 13761564 WebcastA live webcast and one-year archived replay of the call can be accessed on the Events page of the Investor Relations section of Gentherm's website at www.gentherm.com. A telephonic replay will be available approximately
Revenue Growth of 7.2% (ex-FX) Year-over-Year Delivered Record Quarterly Revenue of $394 Million Expanded Gross Margin versus Prior Year as Operational Initiatives Gain Traction Announced Transformational Combination with Modine Performance Technologies; On Track to Close in 2026 NOVI, Mich., April 23, 2026 (GLOBE NEWSWIRE) -- Gentherm (NASDAQ:THRM), a global market leader of innovative thermal management and pneumatic comfort technologies, today announced its financial results for the first quarter ended March 31, 2026. "Our team executed well in the first quarter. We started seeing the tangible results from our efforts to establish a more robust operating system which drove improved
SC 13G/A - GENTHERM Inc (0000903129) (Subject)
SC 13G - GENTHERM Inc (0000903129) (Subject)
SC 13G/A - GENTHERM Inc (0000903129) (Subject)